“We have a system that needs fixing.” That comment on the state of the nation’s healthcare system, shared by physician and New York Times correspondent and senior writer Elisabeth Rosenthal, served as the springboard for a high-level summit on the future of health care in the United States. The event drew a who’s who of nationally known health experts, scientists and government officials.
“Leading change.” That was theme for this year’s Cardinal Health Retail Business Conference, held in Washington, D.C., last month at the Gaylord National Resort and Convention Center, from July 23 to 26.
"The consumer healthcare market has experienced a steady stream of mergers and acquisitions in recent years. Some of this has created small ripples — like pebbles being gently tossed into still waters. Then there are the mega-mergers that have had a tsunami-like effect," writes Dave Wendland, Hamacher Resource Group VP, in his latest blog entry.
While drug stores across North America have diversified their mix over the past few years, over-the-counter medications remain at the heart of most every pharmacy retailer's efforts, helping to maintain the drug channel's inherent value as a front-line healthcare provider and the outlet of choice for consumers suffering from a wide range of minor illnesses.
About 30% of top-performing OTC drugs today were once prescription-only medications, Dave Wendland, VP Hamacher Resource Group, noted during a videocast hosted by GMDC, titled “Rx-to-OTC: Getting it Right at Retail.”
Walmart met low second-quarter sales and profit expectations it set for itself, but significantly lowered its full year outlook due to a tepid third-quarter sales forecast and increased e-commerce and healthcare costs.
The majority of Americans report they have had a good year when it comes to their personal health, and are paying more attention to their health compared to just a few years ago, according to From Hope to Cures: PhRMA’s Second Annual National Health Survey.
ThoughtSpot 2014, AmerisourceBergen and Good Neighbor Pharmacy’s annual tradeshow, concluded this weekend after four days of programming focused on helping independent pharmacies navigate industry changes caused by healthcare reform.
Recognizing the important role that community pharmacy plays, McKesson has long focused on providing solutions to help pharmacists improve patient adherence and enhance patient outcomes as evidenced by programs and solutions offered through McKesson Patient Relationship Solutions (MPRS). However, the growing understanding of pharmacists’ impact on adherence and its importance in today’s evolving healthcare landscape has validated pharmacy based solutions as McKesson bolsters its portfolio of tools.
They say the early bird catches the worm, and that was definitely the case as attendees of this year’s McKesson ideaShare conference arrived at some early morning continuing education courses last week that were geared toward enhancing the pharmacy as a business and improving patient outcomes.
On the final day of meetings at McKesson’s ideaShare 2014 Wednesday morning, Ann Richardson Berkey, McKesson SVP public affairs, reviewed the key political issues impacting pharmacy today — from controlled substances to provider status — and closed the session with an interview with Florida Rep. Matt Hudson, R-District 80.